Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
Overview
Authors
Affiliations
A methodology for determining tau PET thresholds is needed to confidently detect early tau deposition. We compared multiple threshold-determining methods in participants who underwent either F-flortaucipir or F-MK-6240 PET scans. F-flortaucipir ( = 798) and F-MK-6240 ( = 216) scans were processed and sampled to obtain regional SUV ratios. Subsamples of the cohorts were based on participant diagnosis, age, amyloid-β status (positive or negative), and neurodegeneration status (positive or negative), creating older-adult (age ≥ 55 y) cognitively unimpaired (amyloid-β-negative, neurodegeneration-negative) and cognitively impaired (mild cognitive impairment/Alzheimer disease, amyloid-β-positive, neurodegeneration-positive) groups, and then were further subsampled via matching to reduce significant differences in diagnostic prevalence, age, and Mini-Mental State Examination score. We used the biostatistical estimation of tau threshold hallmarks (BETTH) algorithm to determine sensitivity and specificity in 6 composite regions. Parametric double receiver operating characteristic analysis yielded the greatest joint sensitivity in 5 of the 6 regions, whereas hierarchic clustering, gaussian mixture modeling, and k-means clustering all yielded perfect joint specificity (2.00) in all regions. When F-flortaucipir and F-MK-6240 are used, Alzheimer disease-related tau status is best assessed using 2 thresholds, a sensitivity one based on parametric double receiver operating characteristic analysis and a specificity one based on gaussian mixture modeling, delimiting an uncertainty zone indicating participants who may require further evaluation.
Gogola A, Lopresti B, Minhas D, Lopez O, Cohen A, Villemagne V Geriatrics (Basel). 2025; 10(1).
PMID: 39997526 PMC: 11855481. DOI: 10.3390/geriatrics10010027.
Huang K, Hsiao I, Huang C, Huang C, Chang H, Huang S Alzheimers Dement. 2025; 21(1):e14297.
PMID: 39777990 PMC: 11772711. DOI: 10.1002/alz.14297.
Zeng X, Lafferty T, Sehrawat A, Chen Y, Ferreira P, Bellaver B Mol Neurodegener. 2024; 19(1):68.
PMID: 39385222 PMC: 11465638. DOI: 10.1186/s13024-024-00753-5.
Gogola A, Cohen A, Snitz B, Minhas D, Tudorascu D, Ikonomovic M J Alzheimers Dis. 2024; 100(s1):S75-S92.
PMID: 39121123 PMC: 11776372. DOI: 10.3233/JAD-240543.
Zeng X, Lafferty T, Sehrawat A, Chen Y, Ferreira P, Bellaver B medRxiv. 2024; .
PMID: 38947065 PMC: 11213097. DOI: 10.1101/2024.06.15.24308975.